David B. Berger - 03 Jan 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP, Bus Ops & Compliance
Signature
s/David B. Berger
Issuer symbol
TNDM
Transactions as of
03 Jan 2022
Net transactions value
-$111,443
Form type
4
Filing time
05 Jan 2022, 18:12:59 UTC
Previous filing
17 Dec 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $18,860 +1,000 +22% $18.86 5,451 03 Jan 2022 Direct F1
transaction TNDM Common Stock Sale $123,595 -830 -15% $148.91 4,621 03 Jan 2022 Direct F2, F3
transaction TNDM Common Stock Sale $25,568 -170 -3.7% $150.40 4,451 03 Jan 2022 Direct F2, F4
holding TNDM Common Stock 242 03 Jan 2022 Berger Family Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $18,860 +1,000 +2% $18.86 50,000 03 Jan 2022 Common Stock 1,000 $18.86 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.
F3 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $148.78 to $149.26. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F4 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.31 to $150.52. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F5 The securities are held by the Berger Family Trust dated April 16, 2008.
F6 The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F7 The expiration date for these options is 10 years from the date of grant.